FLT3 and myelodysplastic syndrome: In MDS, FLT3 mutations are observed in high-risk subgroups and are associated with complex karyotype (30,31). NPM1 and FLT3 mutations are found primarily in AML; however, the presence of these mutations in an MDS patient should alert the clinician about the risk of rapid progression to AML (22).